Indian Journal of Nephrology Home 

CASE REPORT
[View FULLTEXT] [Download PDF]
Year : 2016  |  Volume : 26  |  Issue : 5  |  Page : 370--372

Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium

D Bhandari, KD Jhaveri, HH Shah 
 Department of Medicine, Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center and North Shore University Hospital, Hofstra Northwell School of Medicine, Great Neck, New York, USA

Correspondence Address:
K D Jhaveri
Department of Medicine, Division of Kidney Diseases and Hypertension, Northwell Health, Hofstra Northwell School of Medicine, Great Neck, New York
USA

Optimal therapy and prognosis of crescentic-IgA nephropathy (C-IgAN) are not known. Reported treatment options for C-IgAN include combination of corticosteroids and cyclophosphamide for 6 months. The role of mycophenolate sodium in C-IgAN is unknown. We report a case of C-IgAN that was successfully treated with combination immunosuppressive therapy.

How to cite this article:
Bhandari D, Jhaveri K D, Shah H H. Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium.Indian J Nephrol 2016;26:370-372

How to cite this URL:
Bhandari D, Jhaveri K D, Shah H H. Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium. Indian J Nephrol [serial online] 2016 [cited 2022 Dec 5 ];26:370-372
Available from: https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2016;volume=26;issue=5;spage=370;epage=372;aulast=Bhandari;type=0